APO Research
Talk to an analyst

APO RESEARCH · REPORT

Automated Nucleic Acid Extraction Devices

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Automated Nucleic Acid Extraction Devices Market Outlook and Growth Opportunities 2026

4 July 2026200 pages

Choose your research edition.

Industry ResearchAutomated Nucleic Acid Extraction Devices Industry Research Report 2026150 pages · $2,950 USDIndustry Growth & TrendsGlobal Automated Nucleic Acid Extraction Devices Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Automated Nucleic Acid Extraction Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Automated Nucleic Acid Extraction Devices Market Outlook and Growth Opportunities 2026200 pages · $4,250 USDMarket Analysis & ForecastGlobal Automated Nucleic Acid Extraction Devices Market Analysis and Forecast 2026-2032211 pages · $4,950 USD

Market perspective

The global Automated Nucleic Acid Extraction Devices market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Automated Nucleic Acid Extraction Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Automated Nucleic Acid Extraction Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Automated Nucleic Acid Extraction Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Automated Nucleic Acid Extraction Devices market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Automated Nucleic Acid Extraction Devices market include QIAGEN, Zybio Inc, BioTeke Corporation(wuxi) Co.,Ltd, TianLong Science and Technology Co., Ltd, Sansure Biotech, Jiangsu Bioperfectus Technologies Co., Ltd, Hangzhou Bioer Technology, Daan Gene Co., Ltd and Thermo Fisher Scientific Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Automated Nucleic Acid Extraction Devices market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Automated Nucleic Acid Extraction Devices and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Automated Nucleic Acid Extraction Devices sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Automated Nucleic Acid Extraction Devices market size, projected growth trends, production technologies, key applications, and end-use industries.

Automated Nucleic Acid Extraction Devices Segment by Company

QIAGEN

Zybio Inc

BioTeke Corporation(wuxi) Co.,Ltd

TianLong Science and Technology Co., Ltd

Sansure Biotech

Jiangsu Bioperfectus Technologies Co., Ltd

Hangzhou Bioer Technology

Daan Gene Co., Ltd

Thermo Fisher Scientific Inc

Tecan Trading AG

PerkinElmer, Inc

Merck KGaA

Illumina, Inc.

F. Hoffmann-La Roche Ltd

DiaSorin SpA

Bioneer Corporation

BD

AUTOGEN INC

Analytik Jena GmbH+Co. KG

AccuBioMed Co., Ltd

Automated Nucleic Acid Extraction Devices Segment by Type

Instruments

Kits

Automated Nucleic Acid Extraction Devices Segment by Application

Maternal and Child Health Hospital

CDC

Health Bureau

Hospitals

Other

Automated Nucleic Acid Extraction Devices Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Automated Nucleic Acid Extraction Devices status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Automated Nucleic Acid Extraction Devices market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Automated Nucleic Acid Extraction Devices significant trends, drivers, influence factors in global and regions.

6. To analyze Automated Nucleic Acid Extraction Devices competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Automated Nucleic Acid Extraction Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Automated Nucleic Acid Extraction Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Automated Nucleic Acid Extraction Devices.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Automated Nucleic Acid Extraction Devices market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Automated Nucleic Acid Extraction Devices industry.

Chapter 3: Detailed analysis of Automated Nucleic Acid Extraction Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Automated Nucleic Acid Extraction Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Automated Nucleic Acid Extraction Devices in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Automated Nucleic Acid Extraction Devices Industry Trends Table 2. Automated Nucleic Acid Extraction Devices Industry Drivers Table 3. Automated Nucleic Acid Extraction Devices Industry Opportunities and Challenges Table 4. Automated Nucleic Acid Extraction Devices Industry Restraints Table 5. Global Automated Nucleic Acid Extraction Devices Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Automated Nucleic Acid Extraction Devices Revenue Share by Company (2021-2026) Table 7. Global Automated Nucleic Acid Extraction Devices Sales Volume by Company (t) & (2021-2026) Table 8. Global Automated Nucleic Acid Extraction Devices Sales Volume Share by Company (2021-2026) Table 9. Global Automated Nucleic Acid Extraction Devices Average Price (USD/t) of Company (2021-2026) Table 10. Global Automated Nucleic Acid Extraction Devices Company Ranking, (2024-2026) & (USD Million) Table 11. Global Automated Nucleic Acid Extraction Devices Key Company Manufacturing Base & Headquarters Table 12. Global Automated Nucleic Acid Extraction Devices Company, Product Type & Application Table 13. Global Automated Nucleic Acid Extraction Devices Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Automated Nucleic Acid Extraction Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Instruments Table 18. Significant Companies of Kits Table 19. Global Automated Nucleic Acid Extraction Devices Sales Volume by Type 2021 VS 2025 VS 2032 (t) Table 20. Global Automated Nucleic Acid Extraction Devices Sales Volume by Type (2021-2026) & (t) Table 21. Global Automated Nucleic Acid Extraction Devices Sales Volume by Type (2027-2032) & (t) Table 22. Global Automated Nucleic Acid Extraction Devices Sales Volume Share by Type (2021-2026) Table 23. Global Automated Nucleic Acid Extraction Devices Sales Volume Share by Type (2027-2032) Table 24. Global Automated Nucleic Acid Extraction Devices Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Automated Nucleic Acid Extraction Devices Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Automated Nucleic Acid Extraction Devices Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Automated Nucleic Acid Extraction Devices Sales Value Share by Type (2021-2026) Table 28. Global Automated Nucleic Acid Extraction Devices Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Maternal and Child Health Hospital Table 30. Significant Companies of CDC Table 31. Significant Companies of Health Bureau Table 32. Significant Companies of Hospitals Table 33. Significant Companies of Other Table 34. Global Automated Nucleic Acid Extraction Devices Sales Volume by Application 2021 VS 2025 VS 2032 (t) Table 35. Global Automated Nucleic Acid Extraction Devices Sales Volume by Application (2021-2026) & (t) Table 36. Global Automated Nucleic Acid Extraction Devices Sales Volume by Application (2027-2032) & (t) Table 37. Global Automated Nucleic Acid Extraction Devices Sales Volume Share by Application (2021-2026) Table 38. Global Automated Nucleic Acid Extraction Devices Sales Volume Share by Application (2027-2032) Table 39. Global Automated Nucleic Acid Extraction Devices Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Automated Nucleic Acid Extraction Devices Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Automated Nucleic Acid Extraction Devices Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Automated Nucleic Acid Extraction Devices Sales Value Share by Application (2021-2026) Table 43. Global Automated Nucleic Acid Extraction Devices Sales Value Share by Application (2027-2032) Table 44. Global Automated Nucleic Acid Extraction Devices Sales by Region: 2021 VS 2025 VS 2032 (t) Table 45. Global Automated Nucleic Acid Extraction Devices Sales by Region (2021-2026) & (t) Table 46. Global Automated Nucleic Acid Extraction Devices Sales Market Share by Region (2021-2026) Table 47. Global Automated Nucleic Acid Extraction Devices Sales by Region (2027-2032) & (t) Table 48. Global Automated Nucleic Acid Extraction Devices Sales Market Share by Region (2027-2032) Table 49. Global Automated Nucleic Acid Extraction Devices Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Automated Nucleic Acid Extraction Devices Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Automated Nucleic Acid Extraction Devices Sales Value Share by Region (2021-2026) Table 52. Global Automated Nucleic Acid Extraction Devices Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Automated Nucleic Acid Extraction Devices Sales Value Share by Region (2027-2032) Table 54. Global Automated Nucleic Acid Extraction Devices Market Average Price (USD/t) by Region (2021-2026) Table 55. Global Automated Nucleic Acid Extraction Devices Market Average Price (USD/t) by Region (2027-2032) Table 56. Global Automated Nucleic Acid Extraction Devices Sales by Country: 2021 VS 2025 VS 2032 (t) Table 57. Global Automated Nucleic Acid Extraction Devices Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Automated Nucleic Acid Extraction Devices Sales by Country (2021-2026) & (t) Table 59. Global Automated Nucleic Acid Extraction Devices Sales Market Share by Country (2021-2026) Table 60. Global Automated Nucleic Acid Extraction Devices Sales by Country (2027-2032) & (t) Table 61. Global Automated Nucleic Acid Extraction Devices Sales Market Share by Country (2027-2032) Table 62. Global Automated Nucleic Acid Extraction Devices Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Automated Nucleic Acid Extraction Devices Sales Value Market Share by Country (2021-2026) Table 64. Global Automated Nucleic Acid Extraction Devices Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Automated Nucleic Acid Extraction Devices Sales Value Market Share by Country (2027-2032) Table 66. QIAGEN Company Information Table 67. QIAGEN Business Overview Table 68. QIAGEN Automated Nucleic Acid Extraction Devices Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 69. QIAGEN Automated Nucleic Acid Extraction Devices Product Portfolio Table 70. QIAGEN Recent Development Table 71. Zybio Inc Company Information Table 72. Zybio Inc Business Overview Table 73. Zybio Inc Automated Nucleic Acid Extraction Devices Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 74. Zybio Inc Automated Nucleic Acid Extraction Devices Product Portfolio Table 75. Zybio Inc Recent Development Table 76. BioTeke Corporation(wuxi) Co.,Ltd Company Information Table 77. BioTeke Corporation(wuxi) Co.,Ltd Business Overview Table 78. BioTeke Corporation(wuxi) Co.,Ltd Automated Nucleic Acid Extraction Devices Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 79. BioTeke Corporation(wuxi) Co.,Ltd Automated Nucleic Acid Extraction Devices Product Portfolio Table 80. BioTeke Corporation(wuxi) Co.,Ltd Recent Development Table 81. TianLong Science and Technology Co., Ltd Company Information Table 82. TianLong Science and Technology Co., Ltd Business Overview Table 83. TianLong Science and Technology Co., Ltd Automated Nucleic Acid Extraction Devices Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 84. TianLong Science and Technology Co., Ltd Automated Nucleic Acid Extraction Devices Product Portfolio Table 85. TianLong Science and Technology Co., Ltd Recent Development Table 86. Sansure Biotech Company Information Table 87. Sansure Biotech Business Overview Table 88. Sansure Biotech Automated Nucleic Acid Extraction Devices Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 89. Sansure Biotech Automated Nucleic Acid Extraction Devices Product Portfolio Table 90. Sansure Biotech Recent Development Table 91. Jiangsu Bioperfectus Technologies Co., Ltd Company Information Table 92. Jiangsu Bioperfectus Technologies Co., Ltd Business Overview Table 93. Jiangsu Bioperfectus Technologies Co., Ltd Automated Nucleic Acid Extraction Devices Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 94. Jiangsu Bioperfectus Technologies Co., Ltd Automated Nucleic Acid Extraction Devices Product Portfolio Table 95. Jiangsu Bioperfectus Technologies Co., Ltd Recent Development Table 96. Hangzhou Bioer Technology Company Information Table 97. Hangzhou Bioer Technology Business Overview Table 98. Hangzhou Bioer Technology Automated Nucleic Acid Extraction Devices Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 99. Hangzhou Bioer Technology Automated Nucleic Acid Extraction Devices Product Portfolio Table 100. Hangzhou Bioer Technology Recent Development Table 101. Daan Gene Co., Ltd Company Information Table 102. Daan Gene Co., Ltd Business Overview Table 103. Daan Gene Co., Ltd Automated Nucleic Acid Extraction Devices Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 104. Daan Gene Co., Ltd Automated Nucleic Acid Extraction Devices Product Portfolio Table 105. Daan Gene Co., Ltd Recent Development Table 106. Thermo Fisher Scientific Inc Company Information Table 107. Thermo Fisher Scientific Inc Business Overview Table 108. Thermo Fisher Scientific Inc Automated Nucleic Acid Extraction Devices Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 109. Thermo Fisher Scientific Inc Automated Nucleic Acid Extraction Devices Product Portfolio Table 110. Thermo Fisher Scientific Inc Recent Development Table 111. Tecan Trading AG Company Information Table 112. Tecan Trading AG Business Overview Table 113. Tecan Trading AG Automated Nucleic Acid Extraction Devices Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 114. Tecan Trading AG Automated Nucleic Acid Extraction Devices Product Portfolio Table 115. Tecan Trading AG Recent Development Table 116. PerkinElmer, Inc Company Information Table 117. PerkinElmer, Inc Business Overview Table 118. PerkinElmer, Inc Automated Nucleic Acid Extraction Devices Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 119. PerkinElmer, Inc Automated Nucleic Acid Extraction Devices Product Portfolio Table 120. PerkinElmer, Inc Recent Development Table 121. Merck KGaA Company Information Table 122. Merck KGaA Business Overview Table 123. Merck KGaA Automated Nucleic Acid Extraction Devices Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 124. Merck KGaA Automated Nucleic Acid Extraction Devices Product Portfolio Table 125. Merck KGaA Recent Development Table 126. Illumina, Inc. Company Information Table 127. Illumina, Inc. Business Overview Table 128. Illumina, Inc. Automated Nucleic Acid Extraction Devices Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 129. Illumina, Inc. Automated Nucleic Acid Extraction Devices Product Portfolio Table 130. Illumina, Inc. Recent Development Table 131. F. Hoffmann-La Roche Ltd Company Information Table 132. F. Hoffmann-La Roche Ltd Business Overview Table 133. F. Hoffmann-La Roche Ltd Automated Nucleic Acid Extraction Devices Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 134. F. Hoffmann-La Roche Ltd Automated Nucleic Acid Extraction Devices Product Portfolio Table 135. F. Hoffmann-La Roche Ltd Recent Development Table 136. DiaSorin SpA Company Information Table 137. DiaSorin SpA Business Overview Table 138. DiaSorin SpA Automated Nucleic Acid Extraction Devices Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 139. DiaSorin SpA Automated Nucleic Acid Extraction Devices Product Portfolio Table 140. DiaSorin SpA Recent Development Table 141. Bioneer Corporation Company Information Table 142. Bioneer Corporation Business Overview Table 143. Bioneer Corporation Automated Nucleic Acid Extraction Devices Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 144. Bioneer Corporation Automated Nucleic Acid Extraction Devices Product Portfolio Table 145. Bioneer Corporation Recent Development Table 146. BD Company Information Table 147. BD Business Overview Table 148. BD Automated Nucleic Acid Extraction Devices Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 149. BD Automated Nucleic Acid Extraction Devices Product Portfolio Table 150. BD Recent Development Table 151. AUTOGEN INC Company Information Table 152. AUTOGEN INC Business Overview Table 153. AUTOGEN INC Automated Nucleic Acid Extraction Devices Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 154. AUTOGEN INC Automated Nucleic Acid Extraction Devices Product Portfolio Table 155. AUTOGEN INC Recent Development Table 156. Analytik Jena GmbH+Co. KG Company Information Table 157. Analytik Jena GmbH+Co. KG Business Overview Table 158. Analytik Jena GmbH+Co. KG Automated Nucleic Acid Extraction Devices Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 159. Analytik Jena GmbH+Co. KG Automated Nucleic Acid Extraction Devices Product Portfolio Table 160. Analytik Jena GmbH+Co. KG Recent Development Table 161. AccuBioMed Co., Ltd Company Information Table 162. AccuBioMed Co., Ltd Business Overview Table 163. AccuBioMed Co., Ltd Automated Nucleic Acid Extraction Devices Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 164. AccuBioMed Co., Ltd Automated Nucleic Acid Extraction Devices Product Portfolio Table 165. AccuBioMed Co., Ltd Recent Development Table 166. Key Raw Materials Table 167. Raw Materials Key Suppliers Table 168. Automated Nucleic Acid Extraction Devices Distributors List Table 169. Automated Nucleic Acid Extraction Devices Customers List Table 170. Research Programs/Design for This Report Table 171. Authors List of This Report Table 172. Secondary Sources Table 173. Primary Sources List of Figures Figure 1. Automated Nucleic Acid Extraction Devices Product Image Figure 2. Global Automated Nucleic Acid Extraction Devices Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Automated Nucleic Acid Extraction Devices Sales Value (2021-2032) & (US$ Million) Figure 4. Global Automated Nucleic Acid Extraction Devices Sales (2021-2032) & (t) Figure 5. Global Automated Nucleic Acid Extraction Devices Sales Average Price (USD/t) & (2021-2032) Figure 6. Global Automated Nucleic Acid Extraction Devices Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Instruments Image Figure 10. Kits Image Figure 11. Global Automated Nucleic Acid Extraction Devices Sales Volume by Type (2021 VS 2025 VS 2032) & (t) Figure 12. Global Automated Nucleic Acid Extraction Devices Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Automated Nucleic Acid Extraction Devices Sales Volume Share by Type (2021-2032) Figure 14. Global Automated Nucleic Acid Extraction Devices Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Automated Nucleic Acid Extraction Devices Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Automated Nucleic Acid Extraction Devices Sales Value Share by Type (2021-2032) Figure 17. Maternal and Child Health Hospital Image Figure 18. CDC Image Figure 19. Health Bureau Image Figure 20. Hospitals Image Figure 21. Other Image Figure 22. Global Automated Nucleic Acid Extraction Devices Sales Volume by Application (2021 VS 2025 VS 2032) & (t) Figure 23. Global Automated Nucleic Acid Extraction Devices Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Automated Nucleic Acid Extraction Devices Sales Volume Share by Application (2021-2032) Figure 25. Global Automated Nucleic Acid Extraction Devices Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Automated Nucleic Acid Extraction Devices Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Automated Nucleic Acid Extraction Devices Sales Value Share by Application (2021-2032) Figure 28. Global Automated Nucleic Acid Extraction Devices Sales by Region: 2021 VS 2025 VS 2032 (t) Figure 29. Global Automated Nucleic Acid Extraction Devices Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Automated Nucleic Acid Extraction Devices Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Automated Nucleic Acid Extraction Devices Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Automated Nucleic Acid Extraction Devices Sales Value (2021-2032) & (US$ Million) Figure 33. North America Automated Nucleic Acid Extraction Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Automated Nucleic Acid Extraction Devices Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Automated Nucleic Acid Extraction Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Automated Nucleic Acid Extraction Devices Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Automated Nucleic Acid Extraction Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Automated Nucleic Acid Extraction Devices Sales Value (2021-2032) & (US$ Million) Figure 39. South America Automated Nucleic Acid Extraction Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Automated Nucleic Acid Extraction Devices Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Automated Nucleic Acid Extraction Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Automated Nucleic Acid Extraction Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Automated Nucleic Acid Extraction Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Automated Nucleic Acid Extraction Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Automated Nucleic Acid Extraction Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Automated Nucleic Acid Extraction Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Automated Nucleic Acid Extraction Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Automated Nucleic Acid Extraction Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Automated Nucleic Acid Extraction Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Automated Nucleic Acid Extraction Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Automated Nucleic Acid Extraction Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Automated Nucleic Acid Extraction Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Automated Nucleic Acid Extraction Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Automated Nucleic Acid Extraction Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Automated Nucleic Acid Extraction Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Automated Nucleic Acid Extraction Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Automated Nucleic Acid Extraction Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Automated Nucleic Acid Extraction Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Automated Nucleic Acid Extraction Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Automated Nucleic Acid Extraction Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Automated Nucleic Acid Extraction Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Automated Nucleic Acid Extraction Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Automated Nucleic Acid Extraction Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Automated Nucleic Acid Extraction Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Automated Nucleic Acid Extraction Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Automated Nucleic Acid Extraction Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Automated Nucleic Acid Extraction Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Automated Nucleic Acid Extraction Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Automated Nucleic Acid Extraction Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Automated Nucleic Acid Extraction Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Automated Nucleic Acid Extraction Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Automated Nucleic Acid Extraction Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Automated Nucleic Acid Extraction Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Automated Nucleic Acid Extraction Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Automated Nucleic Acid Extraction Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Automated Nucleic Acid Extraction Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Automated Nucleic Acid Extraction Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Automated Nucleic Acid Extraction Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Automated Nucleic Acid Extraction Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Automated Nucleic Acid Extraction Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Automated Nucleic Acid Extraction Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Automated Nucleic Acid Extraction Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Automated Nucleic Acid Extraction Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Automated Nucleic Acid Extraction Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Automated Nucleic Acid Extraction Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Automated Nucleic Acid Extraction Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Automated Nucleic Acid Extraction Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Automated Nucleic Acid Extraction Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Automated Nucleic Acid Extraction Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Automated Nucleic Acid Extraction Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Automated Nucleic Acid Extraction Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Automated Nucleic Acid Extraction Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Automated Nucleic Acid Extraction Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Automated Nucleic Acid Extraction Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Automated Nucleic Acid Extraction Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Automated Nucleic Acid Extraction Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Automated Nucleic Acid Extraction Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Automated Nucleic Acid Extraction Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Automated Nucleic Acid Extraction Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Automated Nucleic Acid Extraction Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Automated Nucleic Acid Extraction Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Automated Nucleic Acid Extraction Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Automated Nucleic Acid Extraction Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Automated Nucleic Acid Extraction Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Automated Nucleic Acid Extraction Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Automated Nucleic Acid Extraction Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Automated Nucleic Acid Extraction Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Automated Nucleic Acid Extraction Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Automated Nucleic Acid Extraction Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Automated Nucleic Acid Extraction Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Automated Nucleic Acid Extraction Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Automated Nucleic Acid Extraction Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Automated Nucleic Acid Extraction Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Automated Nucleic Acid Extraction Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Automated Nucleic Acid Extraction Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Automated Nucleic Acid Extraction Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Automated Nucleic Acid Extraction Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Automated Nucleic Acid Extraction Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Automated Nucleic Acid Extraction Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Automated Nucleic Acid Extraction Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Automated Nucleic Acid Extraction Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Automated Nucleic Acid Extraction Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Automated Nucleic Acid Extraction Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Automated Nucleic Acid Extraction Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Automated Nucleic Acid Extraction Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Automated Nucleic Acid Extraction Devices Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Automated Nucleic Acid Extraction Devices Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Instruments
  • Kits
Applications
  • Maternal and Child Health Hospital
  • CDC
  • Health Bureau
  • Hospitals
  • Other
Companies covered
  • QIAGEN
  • Zybio Inc
  • BioTeke Corporation(wuxi) Co.,Ltd
  • TianLong Science and Technology Co., Ltd
  • Sansure Biotech
  • Jiangsu Bioperfectus Technologies Co., Ltd
  • Hangzhou Bioer Technology
  • Daan Gene Co., Ltd
  • Thermo Fisher Scientific Inc
  • Tecan Trading AG
  • PerkinElmer, Inc
  • Merck KGaA
  • Illumina, Inc.
  • F. Hoffmann-La Roche Ltd
  • DiaSorin SpA
  • Bioneer Corporation
  • BD
  • AUTOGEN INC
  • Analytik Jena GmbH+Co. KG
  • AccuBioMed Co., Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Automated Nucleic Acid Extraction Devices Sales Value (2021-2032)
  4. 1.2.2 Global Automated Nucleic Acid Extraction Devices Sales Volume (2021-2032)
  5. 1.2.3 Global Automated Nucleic Acid Extraction Devices Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Automated Nucleic Acid Extraction Devices Market Dynamics
  1. 2.1 Automated Nucleic Acid Extraction Devices Industry Trends
  2. 2.2 Automated Nucleic Acid Extraction Devices Industry Drivers
  3. 2.3 Automated Nucleic Acid Extraction Devices Industry Opportunities and Challenges
  4. 2.4 Automated Nucleic Acid Extraction Devices Industry Restraints
3 Automated Nucleic Acid Extraction Devices Market by Company
  1. 3.1 Global Automated Nucleic Acid Extraction Devices Company Revenue Ranking in 2025
  2. 3.2 Global Automated Nucleic Acid Extraction Devices Revenue by Company (2021-2026)
  3. 3.3 Global Automated Nucleic Acid Extraction Devices Sales Volume by Company (2021-2026)
  4. 3.4 Global Automated Nucleic Acid Extraction Devices Average Price by Company (2021-2026)
  5. 3.5 Global Automated Nucleic Acid Extraction Devices Company Ranking (2024-2026)
  6. 3.6 Global Automated Nucleic Acid Extraction Devices Company Manufacturing Base and Headquarters
  7. 3.7 Global Automated Nucleic Acid Extraction Devices Company Product Type and Application
  8. 3.8 Global Automated Nucleic Acid Extraction Devices Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Automated Nucleic Acid Extraction Devices Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Automated Nucleic Acid Extraction Devices Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Automated Nucleic Acid Extraction Devices Market by Type
  1. 4.1 Automated Nucleic Acid Extraction Devices Type Introduction
  2. 4.1.1 Instruments
  3. 4.1.2 Kits
  4. 4.2 Global Automated Nucleic Acid Extraction Devices Sales Volume by Type
  5. 4.2.1 Global Automated Nucleic Acid Extraction Devices Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Automated Nucleic Acid Extraction Devices Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Automated Nucleic Acid Extraction Devices Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Automated Nucleic Acid Extraction Devices Sales Value by Type
  9. 4.3.1 Global Automated Nucleic Acid Extraction Devices Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Automated Nucleic Acid Extraction Devices Sales Value by Type (2021-2032)
  11. 4.3.3 Global Automated Nucleic Acid Extraction Devices Sales Value Share by Type (2021-2032)
5 Automated Nucleic Acid Extraction Devices Market by Application
  1. 5.1 Automated Nucleic Acid Extraction Devices Application Introduction
  2. 5.1.1 Maternal and Child Health Hospital
  3. 5.1.2 CDC
  4. 5.1.3 Health Bureau
  5. 5.1.4 Hospitals
  6. 5.1.5 Other
  7. 5.2 Global Automated Nucleic Acid Extraction Devices Sales Volume by Application
  8. 5.2.1 Global Automated Nucleic Acid Extraction Devices Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Automated Nucleic Acid Extraction Devices Sales Volume by Application (2021-2032)
  10. 5.2.3 Global Automated Nucleic Acid Extraction Devices Sales Volume Share by Application (2021-2032)
  11. 5.3 Global Automated Nucleic Acid Extraction Devices Sales Value by Application
  12. 5.3.1 Global Automated Nucleic Acid Extraction Devices Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Automated Nucleic Acid Extraction Devices Sales Value by Application (2021-2032)
  14. 5.3.3 Global Automated Nucleic Acid Extraction Devices Sales Value Share by Application (2021-2032)
6 Automated Nucleic Acid Extraction Devices Regional Sales and Value Analysis
  1. 6.1 Global Automated Nucleic Acid Extraction Devices Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Automated Nucleic Acid Extraction Devices Sales by Region (2021-2032)
  3. 6.2.1 Global Automated Nucleic Acid Extraction Devices Sales by Region: 2021-2026
  4. 6.2.2 Global Automated Nucleic Acid Extraction Devices Sales by Region (2027-2032)
  5. 6.3 Global Automated Nucleic Acid Extraction Devices Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Automated Nucleic Acid Extraction Devices Sales Value by Region (2021-2032)
  7. 6.4.1 Global Automated Nucleic Acid Extraction Devices Sales Value by Region: 2021-2026
  8. 6.4.2 Global Automated Nucleic Acid Extraction Devices Sales Value by Region (2027-2032)
  9. 6.5 Global Automated Nucleic Acid Extraction Devices Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Automated Nucleic Acid Extraction Devices Sales Value (2021-2032)
  12. 6.6.2 North America Automated Nucleic Acid Extraction Devices Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Automated Nucleic Acid Extraction Devices Sales Value (2021-2032)
  15. 6.7.2 Europe Automated Nucleic Acid Extraction Devices Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Automated Nucleic Acid Extraction Devices Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Automated Nucleic Acid Extraction Devices Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Automated Nucleic Acid Extraction Devices Sales Value (2021-2032)
  21. 6.9.2 South America Automated Nucleic Acid Extraction Devices Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Automated Nucleic Acid Extraction Devices Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Automated Nucleic Acid Extraction Devices Sales Value Share by Country, 2025 VS 2032
7 Automated Nucleic Acid Extraction Devices Country-level Sales and Value Analysis
  1. 7.1 Global Automated Nucleic Acid Extraction Devices Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Automated Nucleic Acid Extraction Devices Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Automated Nucleic Acid Extraction Devices Sales by Country (2021-2032)
  4. 7.3.1 Global Automated Nucleic Acid Extraction Devices Sales by Country (2021-2026)
  5. 7.3.2 Global Automated Nucleic Acid Extraction Devices Sales by Country (2027-2032)
  6. 7.4 Global Automated Nucleic Acid Extraction Devices Sales Value by Country (2021-2032)
  7. 7.4.1 Global Automated Nucleic Acid Extraction Devices Sales Value by Country (2021-2026)
  8. 7.4.2 Global Automated Nucleic Acid Extraction Devices Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Automated Nucleic Acid Extraction Devices Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Automated Nucleic Acid Extraction Devices Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Automated Nucleic Acid Extraction Devices Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Automated Nucleic Acid Extraction Devices Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Automated Nucleic Acid Extraction Devices Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Automated Nucleic Acid Extraction Devices Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Automated Nucleic Acid Extraction Devices Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Automated Nucleic Acid Extraction Devices Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Automated Nucleic Acid Extraction Devices Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Automated Nucleic Acid Extraction Devices Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Automated Nucleic Acid Extraction Devices Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Automated Nucleic Acid Extraction Devices Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Automated Nucleic Acid Extraction Devices Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Automated Nucleic Acid Extraction Devices Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Automated Nucleic Acid Extraction Devices Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Automated Nucleic Acid Extraction Devices Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Automated Nucleic Acid Extraction Devices Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Automated Nucleic Acid Extraction Devices Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Automated Nucleic Acid Extraction Devices Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Automated Nucleic Acid Extraction Devices Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Automated Nucleic Acid Extraction Devices Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Automated Nucleic Acid Extraction Devices Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Automated Nucleic Acid Extraction Devices Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Automated Nucleic Acid Extraction Devices Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Automated Nucleic Acid Extraction Devices Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Automated Nucleic Acid Extraction Devices Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Automated Nucleic Acid Extraction Devices Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Automated Nucleic Acid Extraction Devices Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Automated Nucleic Acid Extraction Devices Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Automated Nucleic Acid Extraction Devices Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Automated Nucleic Acid Extraction Devices Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Automated Nucleic Acid Extraction Devices Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Automated Nucleic Acid Extraction Devices Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Automated Nucleic Acid Extraction Devices Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Automated Nucleic Acid Extraction Devices Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Automated Nucleic Acid Extraction Devices Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Automated Nucleic Acid Extraction Devices Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Automated Nucleic Acid Extraction Devices Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Automated Nucleic Acid Extraction Devices Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Automated Nucleic Acid Extraction Devices Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Automated Nucleic Acid Extraction Devices Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Automated Nucleic Acid Extraction Devices Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Automated Nucleic Acid Extraction Devices Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Automated Nucleic Acid Extraction Devices Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Automated Nucleic Acid Extraction Devices Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Automated Nucleic Acid Extraction Devices Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Automated Nucleic Acid Extraction Devices Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Automated Nucleic Acid Extraction Devices Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Automated Nucleic Acid Extraction Devices Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Automated Nucleic Acid Extraction Devices Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Automated Nucleic Acid Extraction Devices Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Automated Nucleic Acid Extraction Devices Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Automated Nucleic Acid Extraction Devices Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Automated Nucleic Acid Extraction Devices Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Automated Nucleic Acid Extraction Devices Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Automated Nucleic Acid Extraction Devices Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Automated Nucleic Acid Extraction Devices Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Automated Nucleic Acid Extraction Devices Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Automated Nucleic Acid Extraction Devices Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Automated Nucleic Acid Extraction Devices Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Automated Nucleic Acid Extraction Devices Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Automated Nucleic Acid Extraction Devices Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Automated Nucleic Acid Extraction Devices Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Automated Nucleic Acid Extraction Devices Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Automated Nucleic Acid Extraction Devices Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Automated Nucleic Acid Extraction Devices Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Automated Nucleic Acid Extraction Devices Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Automated Nucleic Acid Extraction Devices Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Automated Nucleic Acid Extraction Devices Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Automated Nucleic Acid Extraction Devices Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Automated Nucleic Acid Extraction Devices Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Automated Nucleic Acid Extraction Devices Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Automated Nucleic Acid Extraction Devices Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Automated Nucleic Acid Extraction Devices Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Automated Nucleic Acid Extraction Devices Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Automated Nucleic Acid Extraction Devices Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Automated Nucleic Acid Extraction Devices Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Automated Nucleic Acid Extraction Devices Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Automated Nucleic Acid Extraction Devices Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Automated Nucleic Acid Extraction Devices Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Automated Nucleic Acid Extraction Devices Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Automated Nucleic Acid Extraction Devices Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Automated Nucleic Acid Extraction Devices Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Automated Nucleic Acid Extraction Devices Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 QIAGEN
  2. 8.1.1 QIAGEN Company Information
  3. 8.1.2 QIAGEN Business Overview
  4. 8.1.3 QIAGEN Automated Nucleic Acid Extraction Devices Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 QIAGEN Automated Nucleic Acid Extraction Devices Product Portfolio
  6. 8.1.5 QIAGEN Recent Developments
  7. 8.2 Zybio Inc
  8. 8.2.1 Zybio Inc Company Information
  9. 8.2.2 Zybio Inc Business Overview
  10. 8.2.3 Zybio Inc Automated Nucleic Acid Extraction Devices Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Zybio Inc Automated Nucleic Acid Extraction Devices Product Portfolio
  12. 8.2.5 Zybio Inc Recent Developments
  13. 8.3 BioTeke Corporation(wuxi) Co.,Ltd
  14. 8.3.1 BioTeke Corporation(wuxi) Co.,Ltd Company Information
  15. 8.3.2 BioTeke Corporation(wuxi) Co.,Ltd Business Overview
  16. 8.3.3 BioTeke Corporation(wuxi) Co.,Ltd Automated Nucleic Acid Extraction Devices Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 BioTeke Corporation(wuxi) Co.,Ltd Automated Nucleic Acid Extraction Devices Product Portfolio
  18. 8.3.5 BioTeke Corporation(wuxi) Co.,Ltd Recent Developments
  19. 8.4 TianLong Science and Technology Co., Ltd
  20. 8.4.1 TianLong Science and Technology Co., Ltd Company Information
  21. 8.4.2 TianLong Science and Technology Co., Ltd Business Overview
  22. 8.4.3 TianLong Science and Technology Co., Ltd Automated Nucleic Acid Extraction Devices Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 TianLong Science and Technology Co., Ltd Automated Nucleic Acid Extraction Devices Product Portfolio
  24. 8.4.5 TianLong Science and Technology Co., Ltd Recent Developments
  25. 8.5 Sansure Biotech
  26. 8.5.1 Sansure Biotech Company Information
  27. 8.5.2 Sansure Biotech Business Overview
  28. 8.5.3 Sansure Biotech Automated Nucleic Acid Extraction Devices Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Sansure Biotech Automated Nucleic Acid Extraction Devices Product Portfolio
  30. 8.5.5 Sansure Biotech Recent Developments
  31. 8.6 Jiangsu Bioperfectus Technologies Co., Ltd
  32. 8.6.1 Jiangsu Bioperfectus Technologies Co., Ltd Company Information
  33. 8.6.2 Jiangsu Bioperfectus Technologies Co., Ltd Business Overview
  34. 8.6.3 Jiangsu Bioperfectus Technologies Co., Ltd Automated Nucleic Acid Extraction Devices Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Jiangsu Bioperfectus Technologies Co., Ltd Automated Nucleic Acid Extraction Devices Product Portfolio
  36. 8.6.5 Jiangsu Bioperfectus Technologies Co., Ltd Recent Developments
  37. 8.7 Hangzhou Bioer Technology
  38. 8.7.1 Hangzhou Bioer Technology Company Information
  39. 8.7.2 Hangzhou Bioer Technology Business Overview
  40. 8.7.3 Hangzhou Bioer Technology Automated Nucleic Acid Extraction Devices Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Hangzhou Bioer Technology Automated Nucleic Acid Extraction Devices Product Portfolio
  42. 8.7.5 Hangzhou Bioer Technology Recent Developments
  43. 8.8 Daan Gene Co., Ltd
  44. 8.8.1 Daan Gene Co., Ltd Company Information
  45. 8.8.2 Daan Gene Co., Ltd Business Overview
  46. 8.8.3 Daan Gene Co., Ltd Automated Nucleic Acid Extraction Devices Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Daan Gene Co., Ltd Automated Nucleic Acid Extraction Devices Product Portfolio
  48. 8.8.5 Daan Gene Co., Ltd Recent Developments
  49. 8.9 Thermo Fisher Scientific Inc
  50. 8.9.1 Thermo Fisher Scientific Inc Company Information
  51. 8.9.2 Thermo Fisher Scientific Inc Business Overview
  52. 8.9.3 Thermo Fisher Scientific Inc Automated Nucleic Acid Extraction Devices Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Thermo Fisher Scientific Inc Automated Nucleic Acid Extraction Devices Product Portfolio
  54. 8.9.5 Thermo Fisher Scientific Inc Recent Developments
  55. 8.10 Tecan Trading AG
  56. 8.10.1 Tecan Trading AG Company Information
  57. 8.10.2 Tecan Trading AG Business Overview
  58. 8.10.3 Tecan Trading AG Automated Nucleic Acid Extraction Devices Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Tecan Trading AG Automated Nucleic Acid Extraction Devices Product Portfolio
  60. 8.10.5 Tecan Trading AG Recent Developments
  61. 8.11 PerkinElmer, Inc
  62. 8.11.1 PerkinElmer, Inc Company Information
  63. 8.11.2 PerkinElmer, Inc Business Overview
  64. 8.11.3 PerkinElmer, Inc Automated Nucleic Acid Extraction Devices Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 PerkinElmer, Inc Automated Nucleic Acid Extraction Devices Product Portfolio
  66. 8.11.5 PerkinElmer, Inc Recent Developments
  67. 8.12 Merck KGaA
  68. 8.12.1 Merck KGaA Company Information
  69. 8.12.2 Merck KGaA Business Overview
  70. 8.12.3 Merck KGaA Automated Nucleic Acid Extraction Devices Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Merck KGaA Automated Nucleic Acid Extraction Devices Product Portfolio
  72. 8.12.5 Merck KGaA Recent Developments
  73. 8.13 Illumina, Inc.
  74. 8.13.1 Illumina, Inc. Company Information
  75. 8.13.2 Illumina, Inc. Business Overview
  76. 8.13.3 Illumina, Inc. Automated Nucleic Acid Extraction Devices Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Illumina, Inc. Automated Nucleic Acid Extraction Devices Product Portfolio
  78. 8.13.5 Illumina, Inc. Recent Developments
  79. 8.14 F. Hoffmann-La Roche Ltd
  80. 8.14.1 F. Hoffmann-La Roche Ltd Company Information
  81. 8.14.2 F. Hoffmann-La Roche Ltd Business Overview
  82. 8.14.3 F. Hoffmann-La Roche Ltd Automated Nucleic Acid Extraction Devices Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 F. Hoffmann-La Roche Ltd Automated Nucleic Acid Extraction Devices Product Portfolio
  84. 8.14.5 F. Hoffmann-La Roche Ltd Recent Developments
  85. 8.15 DiaSorin SpA
  86. 8.15.1 DiaSorin SpA Company Information
  87. 8.15.2 DiaSorin SpA Business Overview
  88. 8.15.3 DiaSorin SpA Automated Nucleic Acid Extraction Devices Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 DiaSorin SpA Automated Nucleic Acid Extraction Devices Product Portfolio
  90. 8.15.5 DiaSorin SpA Recent Developments
  91. 8.16 Bioneer Corporation
  92. 8.16.1 Bioneer Corporation Company Information
  93. 8.16.2 Bioneer Corporation Business Overview
  94. 8.16.3 Bioneer Corporation Automated Nucleic Acid Extraction Devices Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Bioneer Corporation Automated Nucleic Acid Extraction Devices Product Portfolio
  96. 8.16.5 Bioneer Corporation Recent Developments
  97. 8.17 BD
  98. 8.17.1 BD Company Information
  99. 8.17.2 BD Business Overview
  100. 8.17.3 BD Automated Nucleic Acid Extraction Devices Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 BD Automated Nucleic Acid Extraction Devices Product Portfolio
  102. 8.17.5 BD Recent Developments
  103. 8.18 AUTOGEN INC
  104. 8.18.1 AUTOGEN INC Company Information
  105. 8.18.2 AUTOGEN INC Business Overview
  106. 8.18.3 AUTOGEN INC Automated Nucleic Acid Extraction Devices Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 AUTOGEN INC Automated Nucleic Acid Extraction Devices Product Portfolio
  108. 8.18.5 AUTOGEN INC Recent Developments
  109. 8.19 Analytik Jena GmbH+Co. KG
  110. 8.19.1 Analytik Jena GmbH+Co. KG Company Information
  111. 8.19.2 Analytik Jena GmbH+Co. KG Business Overview
  112. 8.19.3 Analytik Jena GmbH+Co. KG Automated Nucleic Acid Extraction Devices Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Analytik Jena GmbH+Co. KG Automated Nucleic Acid Extraction Devices Product Portfolio
  114. 8.19.5 Analytik Jena GmbH+Co. KG Recent Developments
  115. 8.20 AccuBioMed Co., Ltd
  116. 8.20.1 AccuBioMed Co., Ltd Company Information
  117. 8.20.2 AccuBioMed Co., Ltd Business Overview
  118. 8.20.3 AccuBioMed Co., Ltd Automated Nucleic Acid Extraction Devices Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 AccuBioMed Co., Ltd Automated Nucleic Acid Extraction Devices Product Portfolio
  120. 8.20.5 AccuBioMed Co., Ltd Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Automated Nucleic Acid Extraction Devices Value Chain Analysis
  2. 9.1.1 Automated Nucleic Acid Extraction Devices Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Automated Nucleic Acid Extraction Devices Sales Mode & Process
  6. 9.2 Automated Nucleic Acid Extraction Devices Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Automated Nucleic Acid Extraction Devices Distributors
  9. 9.2.3 Automated Nucleic Acid Extraction Devices Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst